The Nippon Foundation Backs Launch of Global Appeal against Stigma, Discrimination



    Representatives of people affected by leprosy today issued Global
    Appeal 2007, in which they call for an end to the stigma and
    discrimination they and their families continue to face. This is a
    historic occasion for people affected by the disease to issue a direct
    appeal to the world. It follows a first Global Appeal issued on their
    behalf by world leaders in New Delhi, India, in January 2006.

    The 16 leprosy affected persons who signed Global Appeal 2007
    include representatives from Angola, Brazil, Cambodia, China,
    Ethiopia, Ghana, India, Indonesia, Japan, Nepal, Nigeria, the
    Philippines and the United States.

    The document also carries the signature of Yohei Sasakawa,
    chairman of The Nippon Foundation and WHO Goodwill Ambassador for the
    Elimination of Leprosy, who took the initiative for issuing both
    Global Appeal 2006 and Global Appeal 2007.

    Global Appeal 2007 states: "Denying the inherent human rights of
    anyone on the basis of disease is indefensible. Discrimination can
    never be justified. Silence on this issue is not acceptable. We urge
    you to join us in the fight to end this social injustice."

    Organizers include: Ateneo de Manila University; Department of
    Health, the Government of the Philippines; the World Health
    Organization; the Philippine Leprosy Mission; The Nippon Foundation
    and the Sasakawa Memorial Health Foundation.

    Leprosy and The Nippon Foundation

    Leprosy is a mildly infectious disease that mainly affects the
    skin and the nerves. It is completely curable with multidrug therapy
    (MDT). Since MDT became widely available in the 1980s, over 15 million
    people have been treated and cured. However, the stigma attached to
    leprosy means that people affected by the disease and even their
    families continue to face obstacles to education, employment and
    marriage.

    Since the 1960s, The Nippon Foundation has supported leprosy
    control efforts in many countries. Since 1975, as a key partner of the
    WHO, it has taken an active effort to eliminate leprosy as public
    health problem, including a five-year program to provide free MDT in
    every country of the world. Since 2003, when Yohei Sasakawa first
    approached the UN Sub-Commission on the Promotion and Protection of
    Human Rights on behalf of people affected by leprosy, The Nippon
    Foundation has actively focused on the social aspects of the disease.